aspirin
Medications
SN instructed patient and caregiver that Apixaban ( Eliquis ) is a anticoagulant for the treatment of venous thromboembolic events. It is indicated for the following: to lower the risk of stroke and embolism in patients with nonvalvular atrial fibrillation, deep vein thrombosis ( DVT ) prophylaxis. DVT's may lead to pulmonary embolism ( PE ) in knee or hip replacement surgery patients, treatment of both DVT and PE, to reduce the risk of recurrent DVT and PE after initial therapy. Apixaban can increase the risk of bleeding and may cause serious, potentially fatal, bleeding. Concurrent use with drugs affecting hemostasis ( e.g. other anticoagulants, heparin, aspirin and other antiplatelet drugs, selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and non steroidal anti-inflammatory drugs ( NSAIDs ) can further increase the risk of bleeding.
Instructed patient on new medication Sulindac. Sulindac may also be used for purposes not listed. Sulindac can increase your risk of fatal heart attack or stroke, especially if you use it long term or take high doses, or if you have heart disease. Even people without heart disease or risk factors could have a stroke or heart attack while taking this medicine. You should not use sulindac if you are allergic to it, or if you have ever had an asthma attack or severe allergic reaction after taking aspirin or an NSAID. Patient verbalized understanding.